---
figid: PMC9023153__ECAM2022-8489699.007
pmcid: PMC9023153
image_filename: ECAM2022-8489699.007.jpg
figure_link: /pmc/articles/PMC9023153/figure/fig7/
number: Figure 7
figure_title: ''
caption: Western blot results of related protein expression levels in the mice kidney
  of all groups (Δp < 0.01, comparable to the S group; ∗∗p < 0.01, comparable to the
  M group; ∗p < 0.05, comparable to the M group; S, sham operation group; M, model
  group; P, positive control group; MDFD-H, modified Dahuang Fuzi Decoction high-dose
  group; MDFD-M, modified Dahuang Fuzi Decoction medium-dose group; MDFD-L, modified
  Dahuang Fuzi Decoction low-dose group; AhR, aryl hydrocarbon receptor; NF-κB, nuclear
  factor-κB; JNK, c-Jun N-terminal kinase).
article_title: Treatment of Modified Dahuang Fuzi Decoction on Cognitive Impairment
  Induced by Chronic Kidney Disease through Regulating AhR/NF-κB/JNK Signal Pathway.
citation: Mingjia Gu, et al. Evid Based Complement Alternat Med. 2022;2022:8489699.
year: '2022'

doi: 10.1155/2022/8489699
journal_title: 'Evidence-based Complementary and Alternative Medicine : eCAM'
journal_nlm_ta: Evid Based Complement Alternat Med
publisher_name: Hindawi

keywords:
---
